1. Innovative Statistical Model Uncover Effective Herbal Medicines Among Personalized Treatment Plans in Persian Medicine: A Small-Scale Study in Type 2 Diabetes.
- Author
-
Eftekhari Mahabadi, Samaneh, Khalifeh, Reza, Ghods, Roshanak, Wieland, L. Susan, Ghelman, Ricardo, Shojaii, Asie, Zareian, Armin, and Hosseini Yekta, Nafiseh
- Subjects
BLOOD sugar analysis ,STATISTICAL models ,HOLISTIC medicine ,RESEARCH funding ,ACADEMIC medical centers ,HEALTH status indicators ,HERBAL medicine ,SCIENTIFIC observation ,DESCRIPTIVE statistics ,PERSIAN medicine ,LONGITUDINAL method ,TYPE 2 diabetes ,DRUG efficacy ,INDIVIDUALIZED medicine ,DATA analysis software ,REGRESSION analysis ,FASTING ,PHARMACEUTICAL encapsulation - Abstract
Objectives: In holistic medicine, developing personalized treatment plans is challenging due to the multitude of possible therapy combinations. This study introduces the use of a statistical approach to identify the most effective herbal medicines prescribed in Persian medicine (PM) in a small-scale sample of patients with type 2 diabetes mellitus (T2DM). Methods: This prospective observational cohort study was conducted with 47 patients with T2DM referred to Behesht Clinic in Tehran, Iran. A physician prescribed individualized PM treatment for T2DM and related systemic issues. The fasting blood sugar (FBS) level of each patient was recorded at initial and two follow-up visits, with visit intervals and treatment modifications determined by patient health status. Patients who completed two follow-up visits were included in the final analysis (n = 27). Data were analyzed using R software. A general linear model was assumed for the mean response, along with an exponential covariance pattern model, to manage irregularly timed measurements. Results: Two fitted models showed that, after adjusting for confounders, the use of the "Diabetes Capsule" significantly reduced the average FBS by 17.14 mmol/L (p = 0.046). For each unit increase in the consumption of "Diabetes Capsule" or "Hab-e-Amber Momiai," the average FBS decreased by 15.22 mmol/L (p = 0.015) and 14.14 mmol/L (p = 0.047), respectively. Conclusion: It is possible to observe which medications are most effective, even when treatments are applied in a holistic and personalized fashion. Preliminary studies such as these may identify promising products for testing in clinical trials conducted under standardized conditions, to inform initial choices for future personalized treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF